Literature DB >> 4115262

Antinuclear antibodies in patients with malignancies.

T K Burnham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4115262     DOI： 10.1016/s0140-6736(72)91842-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis.

Authors:  J Wasserman; U Glas; H Blomgren
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

Review 2.  Serologic laboratory findings in malignancy.

Authors:  Félix Fernández Madrid; Marie-Claire Maroun
Journal:  Rheum Dis Clin North Am       Date:  2011-11       Impact factor: 2.670

3.  Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.

Authors:  Aykan A Karabudak; Julie Hafner; Vivekananda Shetty; Songming Chen; Angeles Alvarez Secord; Michael A Morse; Ramila Philip
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-03       Impact factor: 4.553

4.  Editorial: Autoantibodies in breast cancer.

Authors: 
Journal:  Br Med J       Date:  1976-01-31

5.  Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.

Authors:  Yaron Zafrir; Boris Gilburd; Marina Garcia Carrasco; Shaye Kivity; María Sánchez-Castañón; Marcos López-Hoyos; Mathilda Mandel; Magdalena Szmyrka; Yehuda Shoenfeld; Nancy Agmon-Levin
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

6.  [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].

Authors:  K Helmke; R Scheuermann; T Boeder; M Oppermann; J Teuber; K Federlin
Journal:  Klin Wochenschr       Date:  1981-03-16

7.  Antinuclear antibodies as potential markers of lung cancer.

Authors:  F Fernández-Madrid; P J VandeVord; X Yang; R L Karvonen; P M Simpson; M J Kraut; J L Granda; J E Tomkiel
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

8.  Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Authors:  C Tolosa-Vilella; J Ordi-Ros; M Vilardell-Tarres; A Selva-O'Callaghan; R Jordana-Comajuncosa
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

9.  The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.

Authors:  S A Cairns; E J Acheson; C L Corbett; S Dosa; N P Mallick; W Lawler; G Williams
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

10.  Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.

Authors:  H Imai; R L Ochs; K Kiyosawa; S Furuta; R M Nakamura; E M Tan
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.